August 31, 2022 — Medtronic plc, a global leader in healthcare technology, announced it has entered into a strategic ...
August 31, 2022 — Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than ...
August 31, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), fully automated and normalized body ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
August 30, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest ...
August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents ...
August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...
August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...
August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and ...
August 29, 2022 — ÂThe US Preventive Services Task Force (USPSTF) has issued a Recommendation Statement, relating to ...
August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 26, 2022 — Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients ...
August 26, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program ...
August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...
August 31, 2022
